F, Z., S, R., CF, H., KY, K., AR, G., AT, Z., . . . DM, F. (2025). Preemptive optimization of a clinical antibody for broad neutralization of SARS-CoV-2 variants and robustness against viral escape. Science advances, 11(13), eadu0718. https://doi.org/10.1126/sciadv.adu0718
Chicago Style (17th ed.) CitationF, Zhu, et al. "Preemptive Optimization of a Clinical Antibody for Broad Neutralization of SARS-CoV-2 Variants and Robustness Against Viral Escape." Science Advances 11, no. 13 (2025): eadu0718. https://doi.org/10.1126/sciadv.adu0718.
MLA (9th ed.) CitationF, Zhu, et al. "Preemptive Optimization of a Clinical Antibody for Broad Neutralization of SARS-CoV-2 Variants and Robustness Against Viral Escape." Science Advances, vol. 11, no. 13, 2025, p. eadu0718, https://doi.org/10.1126/sciadv.adu0718.